These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35388724)

  • 1. Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.
    Kopra EI; Ferris JA; Winstock AR; Young AH; Rucker JJ
    J Psychopharmacol; 2022 Aug; 36(8):965-973. PubMed ID: 35388724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceived harm, motivations for use and subjective experiences of recreational psychedelic 'magic' mushroom use.
    Roberts CA; Osborne-Miller I; Cole J; Gage SH; Christiansen P
    J Psychopharmacol; 2020 Sep; 34(9):999-1007. PubMed ID: 32674668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences.
    Shaw L; Rea K; Lachowsky NJ; Roth EA
    J Psychoactive Drugs; 2023; 55(2):151-158. PubMed ID: 35315749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD).
    Kopra EI; Ferris JA; Rucker JJ; McClure B; Young AH; Copeland CS; Winstock AR
    J Psychopharmacol; 2022 Aug; 36(8):956-964. PubMed ID: 35672900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.
    Morton E; Sakai K; Ashtari A; Pleet M; Michalak EE; Woolley J
    J Psychopharmacol; 2023 Jan; 37(1):49-60. PubMed ID: 36515370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Authentication and Chemical Analysis of
    Bradshaw AJ; Backman TA; Ramírez-Cruz V; Forrister DL; Winter JM; Guzmán-Dávalos L; Furci G; Stamets P; Dentinger BTM
    Appl Environ Microbiol; 2022 Dec; 88(24):e0149822. PubMed ID: 36445079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes.
    Nkadimeng SM; Steinmann CML; Eloff JN
    Sci Rep; 2020 Dec; 10(1):22314. PubMed ID: 33339902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature.
    Honyiglo E; Franchi A; Cartiser N; Bottinelli C; Advenier AS; Bévalot F; Fanton L
    J Forensic Sci; 2019 Jul; 64(4):1266-1270. PubMed ID: 30548541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions.
    Beck O; Helander A; Karlson-Stiber C; Stephansson N
    J Anal Toxicol; 1998; 22(1):45-9. PubMed ID: 9491968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.
    Barrett FS; Bradstreet MP; Leoutsakos JS; Johnson MW; Griffiths RR
    J Psychopharmacol; 2016 Dec; 30(12):1279-1295. PubMed ID: 27856683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harm potential of magic mushroom use: a review.
    van Amsterdam J; Opperhuizen A; van den Brink W
    Regul Toxicol Pharmacol; 2011 Apr; 59(3):423-9. PubMed ID: 21256914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injury-Triggered Blueing Reactions of Psilocybe "Magic" Mushrooms.
    Lenz C; Wick J; Braga D; García-Altares M; Lackner G; Hertweck C; Gressler M; Hoffmeister D
    Angew Chem Int Ed Engl; 2020 Jan; 59(4):1450-1454. PubMed ID: 31725937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marketing pitches of 'magic mushrooms' and 'psychedelics' mask that psychotomimetics use exposes those vulnerable to serious adverse effects.
    Braillon A; Naudet F
    J Psychopharmacol; 2023 Jul; 37(7):749-750. PubMed ID: 37132539
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometry.
    Goff R; Smith M; Islam S; Sisley S; Ferguson J; Kuzdzal S; Badal S; Kumar AB; Sreenivasan U; Schug KA
    Anal Chim Acta; 2024 Feb; 1288():342161. PubMed ID: 38220293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hallucinogenic mushrooms on the German market - simple instructions for examination and identification.
    Musshoff F; Madea B; Beike J
    Forensic Sci Int; 2000 Sep; 113(1-3):389-95. PubMed ID: 10978653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hallucinogenic mushrooms].
    Reingardiene D; Vilcinskaite J; Lazauskas R
    Medicina (Kaunas); 2005; 41(12):1067-70. PubMed ID: 16401965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.
    Kopra EI; Ferris JA; Winstock AR; Kuypers KP; Young AH; Rucker JJ
    J Psychopharmacol; 2023 Jul; 37(7):733-748. PubMed ID: 36876583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DARK Classics in Chemical Neuroscience: Psilocybin.
    Geiger HA; Wurst MG; Daniels RN
    ACS Chem Neurosci; 2018 Oct; 9(10):2438-2447. PubMed ID: 29956917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poisonings resulting from the ingestion of magic mushrooms in Kraków.
    Satora L; Goszcz H; Ciszowski K
    Przegl Lek; 2005; 62(6):394-6. PubMed ID: 16225077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms.
    Morita I; Oyama H; Kiguchi Y; Oguri A; Fujimoto N; Takeuchi A; Tanaka R; Ogata J; Kikura-Hanajiri R; Kobayashi N
    J Pharm Biomed Anal; 2020 Oct; 190():113485. PubMed ID: 32866746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.